SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
18-Nov-24 5:31 PM View: | Dyne Therapeutics, Inc. (DYN) | 14-Nov-24 | Private Sale | 782 | $33.10 | $25,884.20 | (< 1%) 8.02M to 8.02M | |
05-Mar-24 5:08 PM View: | Dyne Therapeutics, Inc. (DYN) | 01-Mar-24 | Private Sale (Planned) | 46,534 | $30.05 | $1,398,350.00 | (< 1%) 8.05M to 8.0M | |
28-Feb-24 7:15 PM View: | Dyne Therapeutics, Inc. (DYN) | 28-Feb-24 | Sale (Planned) | 190,920 | $24.84 | $4,741,800.00 | (2%) 8.24M to 8.05M | |
28-Feb-24 7:15 PM View: | Dyne Therapeutics, Inc. (DYN) | 27-Feb-24 | Sale (Planned) | 368,699 | $24.41 | $8,998,430.00 | (4%) 8.61M to 8.24M | |
28-Feb-24 7:15 PM View: | Dyne Therapeutics, Inc. (DYN) | 26-Feb-24 | Private Sale (Planned) | 248,219 | $23.72 | $5,886,670.00 | (3%) 8.86M to 8.61M | |
23-Feb-24 6:59 PM View: | Dyne Therapeutics, Inc. (DYN) | 23-Feb-24 | Sale (Planned) | 196,928 | $22.70 | $4,470,270.00 | (2%) 9.06M to 8.86M | |
23-Feb-24 6:59 PM View: | Dyne Therapeutics, Inc. (DYN) | 22-Feb-24 | Sale (Planned) Duplicate | 119,360 | $22.66 | $2,704,700.00 | (1%) 9.17M to 9.06M | |
23-Feb-24 6:59 PM View: | Dyne Therapeutics, Inc. (DYN) | 21-Feb-24 | Private Sale (Planned) Duplicate | 184,501 | $22.57 | $4,164,820.00 | (2%) 9.36M to 9.17M | |
20-Feb-24 6:36 PM View: | Dyne Therapeutics, Inc. (DYN) | 20-Feb-24 | Sale (Planned) Duplicate | 169,539 | $22.72 | $3,852,650.00 | (2%) 9.53M to 9.36M | |
20-Feb-24 6:36 PM View: | Dyne Therapeutics, Inc. (DYN) | 16-Feb-24 | Sale (Planned) Duplicate | 162,707 | $23.14 | $3,765,040.00 | (2%) 9.69M to 9.53M | |
20-Feb-24 6:36 PM View: | Dyne Therapeutics, Inc. (DYN) | 15-Feb-24 | Private Sale (Planned) Duplicate | 177,906 | $23.89 | $4,249,600.00 | (2%) 9.87M to 9.69M | |
14-Dec-22 4:56 PM View: | Dyne Therapeutics, Inc. (DYN) | 12-Dec-22 | Market Purchase Duplicate | 934,581 | $10.70 | $10,000,000.00 | 10% 8.93M to 9.87M | 1% |
29-Sep-21 7:16 PM View: | Generation Bio Co. (GBIO) | 29-Sep-21 | Market Sale (Planned) | 16,586 | $24.59 | $407,850.00 | (< 1%) 8.3M to 8.28M | (2%) |
29-Sep-21 7:16 PM View: | Generation Bio Co. (GBIO) | 28-Sep-21 | Market Sale (Planned) | 13,113 | $25.24 | $330,972.00 | (< 1%) 8.31M to 8.3M | < 1% |
29-Sep-21 7:16 PM View: | Generation Bio Co. (GBIO) | 27-Sep-21 | Market Sale (Planned) | 51,389 | $25.70 | $1,320,700.00 | (< 1%) 8.36M to 8.31M | 3% |
24-Sep-21 10:00 PM View: | Generation Bio Co. (GBIO) | 24-Sep-21 | Market Sale (Planned) | 28,916 | $25.84 | $747,161.00 | (< 1%) 8.39M to 8.36M | 2% |
24-Sep-21 10:00 PM View: | Generation Bio Co. (GBIO) | 23-Sep-21 | Market Sale (Planned) | 75,465 | $26.13 | $1,972,130.00 | (< 1%) 8.46M to 8.39M | 3% |
24-Sep-21 10:00 PM View: | Generation Bio Co. (GBIO) | 22-Sep-21 | Market Sale (Planned) | 30,617 | $25.89 | $792,705.00 | (< 1%) 8.5M to 8.46M | 2% |
28-Jun-21 4:57 PM View: | Generation Bio Co. (GBIO) | 24-Jun-21 | Market Sale (Planned) | 31,008 | $25.85 | $801,618.00 | (< 1%) 9.41M to 9.38M | (4%) |
23-Jun-21 8:27 PM View: | Generation Bio Co. (GBIO) | 23-Jun-21 | Market Sale (Planned) | 62,609 | $25.36 | $1,587,550.00 | (< 1%) 9.47M to 9.41M | (1%) |
23-Jun-21 8:27 PM View: | Generation Bio Co. (GBIO) | 22-Jun-21 | Market Sale (Planned) | 58,577 | $24.95 | $1,461,480.00 | (< 1%) 9.53M to 9.47M | (3%) |
23-Jun-21 8:27 PM View: | Generation Bio Co. (GBIO) | 21-Jun-21 | Market Sale (Planned) | 63,892 | $24.84 | $1,586,940.00 | (< 1%) 9.6M to 9.53M | (3%) |
14-Apr-21 8:20 PM View: | Generation Bio Co. (GBIO) | 14-Apr-21 | Market Sale (Planned) Duplicate | 23,413 | $26.61 | $622,995.00 | (< 1%) 10.5M to 10.48M | < 1% |
14-Apr-21 8:20 PM View: | Generation Bio Co. (GBIO) | 13-Apr-21 | Market Sale (Planned) Duplicate | 43,145 | $25.17 | $1,085,740.00 | (< 1%) 10.55M to 10.5M | (6%) |
14-Apr-21 8:20 PM View: | Generation Bio Co. (GBIO) | 12-Apr-21 | Market Sale (Planned) Duplicate | 74,124 | $26.15 | $1,938,230.00 | (< 1%) 10.62M to 10.55M | (2%) |
09-Apr-21 8:53 PM View: | Generation Bio Co. (GBIO) | 09-Apr-21 | Market Sale (Planned) Duplicate | 43,681 | $27.61 | $1,205,950.00 | (< 1%) 10.66M to 10.62M | 1% |
09-Apr-21 8:53 PM View: | Generation Bio Co. (GBIO) | 08-Apr-21 | Market Sale (Planned) Duplicate | 43,550 | $28.50 | $1,241,240.00 | (< 1%) 10.71M to 10.66M | 5% |
09-Apr-21 8:53 PM View: | Generation Bio Co. (GBIO) | 07-Apr-21 | Market Sale (Planned) Duplicate | 39,864 | $28.51 | $1,136,670.00 | (< 1%) 10.75M to 10.71M | 5% |
28-Jan-21 5:08 PM View: | Replimune Group, Inc. (REPL) | 26-Jan-21 | Market Sale (Planned) | 5,558 | $46.14 | $256,446.00 | (< 1%) 3.23M to 3.23M | 15% |
22-Dec-20 4:38 PM View: | Replimune Group, Inc. (REPL) | 18-Dec-20 | Market Sale (Planned) | 4,319 | $41.95 | $181,182.00 | (< 1%) 3.24M to 3.23M | < 1% |
17-Dec-20 6:21 PM View: | Replimune Group, Inc. (REPL) | 17-Dec-20 | Market Sale (Planned) | 11,535 | $42.00 | $484,470.00 | (< 1%) 3.25M to 3.24M | < 1% |
17-Dec-20 6:21 PM View: | Replimune Group, Inc. (REPL) | 16-Dec-20 | Market Sale (Planned) | 12,675 | $42.13 | $533,998.00 | (< 1%) 3.26M to 3.25M | < 1% |
17-Dec-20 6:21 PM View: | Replimune Group, Inc. (REPL) | 15-Dec-20 | Market Sale (Planned) | 40,819 | $42.41 | $1,731,250.00 | (1%) 3.3M to 3.26M | 1% |
14-Dec-20 7:20 PM View: | Replimune Group, Inc. (REPL) | 14-Dec-20 | Market Sale (Planned) | 37,659 | $43.49 | $1,637,850.00 | (1%) 3.34M to 3.3M | 4% |
14-Dec-20 7:20 PM View: | Replimune Group, Inc. (REPL) | 11-Dec-20 | Market Sale (Planned) | 31,636 | $43.38 | $1,372,510.00 | (< 1%) 3.37M to 3.34M | 4% |
14-Dec-20 7:20 PM View: | Replimune Group, Inc. (REPL) | 10-Dec-20 | Market Sale (Planned) | 34,391 | $43.15 | $1,484,080.00 | (1%) 3.41M to 3.37M | 3% |
09-Dec-20 7:54 PM View: | Replimune Group, Inc. (REPL) | 09-Dec-20 | Market Sale (Planned) | 41,216 | $43.77 | $1,804,180.00 | (1%) 3.45M to 3.41M | 4% |
09-Dec-20 7:54 PM View: | Replimune Group, Inc. (REPL) | 08-Dec-20 | Market Sale (Planned) | 108,256 | $46.71 | $5,056,590.00 | (3%) 3.56M to 3.45M | 10% |
09-Dec-20 7:54 PM View: | Replimune Group, Inc. (REPL) | 07-Dec-20 | Market Sale (Planned) | 67,890 | $45.96 | $3,120,460.00 | (2%) 3.62M to 3.56M | 9% |
23-Sep-20 7:00 PM View: | Dyne Therapeutics, Inc. (DYN) | 21-Sep-20 | Conversion Duplicate | 7,638,510 | -- | -- | 362% 2.11M to 9.75M | |
18-Jun-20 5:28 PM View: | Generation Bio Co. (GBIO) | 16-Jun-20 | Conversion Duplicate | 10,040,000 | -- | -- | 388% 2.59M to 12.63M | |
20-Nov-19 5:50 PM View: | Replimune Group, Inc. (REPL) | 18-Nov-19 | Market Purchase | 1,100,000 | $13.61 | $14,971,000.00 | 29% 3.83M to 4.93M | 207% |
26-Jul-18 5:19 PM View: | Replimune Group, Inc. (REPL) | 24-Jul-18 | Conversion Duplicate | 4,453,390 | -- | -- | 100% 0 to 4.45M | |
24-Sep-14 6:15 PM View: | Epizyme, Inc. (EPZM) | 22-Sep-14 | Option Exercise | 44,000 | $0.51 | $22,440.00 | 47% 94.0K to 138.0K | |
04-Sep-14 6:41 PM View: | Epizyme, Inc. (EPZM) | 02-Sep-14 | Option Exercise | 42,000 | $1.02 | $42,840.00 | 51% 82.0K to 124.0K | |
04-Sep-14 6:41 PM View: | Epizyme, Inc. (EPZM) | 02-Sep-14 | Market Option Sale (Planned) | 30,000 | $33.47 | $1,004,160.00 | (24%) 124.0K to 94.0K | 67% |
05-Aug-14 6:28 PM View: | Epizyme, Inc. (EPZM) | 04-Aug-14 | Option Exercise | 42,000 | $1.16 | $48,720.00 | 60% 70.0K to 112.0K | |
05-Aug-14 6:28 PM View: | Epizyme, Inc. (EPZM) | 04-Aug-14 | Market Option Sale (Planned) | 30,000 | $29.74 | $892,324.00 | (27%) 112.0K to 82.0K | 63% |
09-Jul-14 6:16 PM View: | Epizyme, Inc. (EPZM) | 07-Jul-14 | Option Exercise | 42,000 | $0.95 | $39,960.00 | 72% 58.0K to 100.0K | |
09-Jul-14 6:16 PM View: | Epizyme, Inc. (EPZM) | 07-Jul-14 | Market Option Sale (Planned) | 30,000 | $32.74 | $982,161.00 | (30%) 100.0K to 70.0K | 67% |